Related references
Note: Only part of the references are listed.Synaptic changes induced by cannabinoid drugs and cannabis use disorder
Shana M. Augustin et al.
NEUROBIOLOGY OF DISEASE (2022)
Cannabinoids: Challenges, opportunities and current techniques towards its extraction and purification for edibles
Sharon Lustenberger et al.
FOOD BIOSCIENCE (2022)
THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways
Hanna J. Szkudlarek et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
The cannabinoid system and microglia in health and disease
Samuel S. Duffy et al.
NEUROPHARMACOLOGY (2021)
Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions
Seulah Choi et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2020)
High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells
Francesca Garofano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
Anastasia S. Suraev et al.
SLEEP MEDICINE REVIEWS (2020)
Cannabinoids and Cannabinoid Receptors: The Story so Far
Fred Shahbazi et al.
ISCIENCE (2020)
Anandamide Metabolites Protect against Seizures through the TRP Channel Water Witch in Drosophila melanogaster
Jack A. Jacobs et al.
CELL REPORTS (2020)
A simple LC-MS/MS method for the simultaneous quantification of endocannabinoids in biological samples
Maria Bobrich et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)
Neuroinflammation in CNS diseases: Molecular mechanisms and the therapeutic potential of plant derived bioactive molecules
Menizibeya O. Welcome
PHARMANUTRITION (2020)
Cannabinoid receptor as a potential therapeutic target for Parkinson's Disease
Himadri Shekhaar Baul et al.
BRAIN RESEARCH BULLETIN (2019)
Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy
Isaac Yao et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Cannabinoid synthases and osmoprotective metabolites accumulate in the exudates of Cannabis sativa L. glandular trichomes
Pawel Rodziewicz et al.
PLANT SCIENCE (2019)
The endocannabinoid system in mental disorders: Evidence from human brain studies
Ines Ibarra-Lecue et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia
Gemma Navarro et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Low-grade neuroinflammation due to chronic sleep deprivation results in anxiety and learning and memory impairments
Shaffi Manchanda et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
β-Amyloid accumulation in the human brain after one night of sleep deprivation
Ehsan Shokri-Kojori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Chronic pain and cannabinoids. Great expectations or a christmas carol
D. Pascual et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Maria S. Aymerich et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Therapeutic applications of cannabinoids
Nancy Maurya et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial
Geke A. H. van den Elsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
Evan C. Rosenberg et al.
EPILEPSY & BEHAVIOR (2017)
Pharmacology of cannabinoids in the treatment of epilepsy
Tyler E. Gaston et al.
EPILEPSY & BEHAVIOR (2017)
Neuroprotective effect of cannabinoids nanoplatforms in neurodegenerative diseases
M. A. Holgado et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2017)
Sleep Loss Promotes Astrocytic Phagocytosis and Microglial Activation in Mouse Cerebral Cortex
Michele Bellesi et al.
JOURNAL OF NEUROSCIENCE (2017)
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Kimberly A. Babson et al.
CURRENT PSYCHIATRY REPORTS (2017)
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials
Victoria P. da Rovare et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2017)
Advances Towards The Discovery of GPR55 Ligands
Paula Morales et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
Farideh A. Javid et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The clinical symptoms of Parkinson's disease
Sigurlaug Sveinbjornsdottir
JOURNAL OF NEUROCHEMISTRY (2016)
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
Yolanda Gomez-Galvez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
M. Mecha et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The choreography of neuroinflammation in Huntington's disease
Andrea Crotti et al.
TRENDS IN IMMUNOLOGY (2015)
Monomeric C-reactive protein-a key molecule driving development of Alzheimer's disease associated with brain ischaemia?
M. Slevin et al.
SCIENTIFIC REPORTS (2015)
Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE
Monica Moreno et al.
JOURNAL OF NEUROSCIENCE (2014)
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting
Filomena Fezza et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2014)
Evaluation of phytocannabinoids from high-potency Cannabis sativa using in vitro bioassays to determine structure-activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2
Afeef S. Husni et al.
MEDICINAL CHEMISTRY RESEARCH (2014)
The effects of cannabinoid administration on sleep: a systematic review of human studies
Peter J. Gates et al.
SLEEP MEDICINE REVIEWS (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients
Maite Solas et al.
NEUROBIOLOGY OF AGING (2013)
Effect of long-term cannabis use on axonal fibre connectivity
Andrew Zalesky et al.
BRAIN (2012)
Sleep disturbance induces neuroinflammation and impairment of learning and memory
Biao Zhu et al.
NEUROBIOLOGY OF DISEASE (2012)
Endocannabinoid system dysfunction in mood and related disorders
C. H. Ashton et al.
ACTA PSYCHIATRICA SCANDINAVICA (2011)
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration
Aoife Gowran et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration
Joanna Mikita et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Sleep loss and inflammation
Janet M. Mullington et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
BEHAVIOURAL AND MOLECULAR CONSEQUENCES OF CHRONIC CANNABINOID TREATMENT IN HUNTINGTON'S DISEASE TRANSGENIC MICE
M. J. Dowie et al.
NEUROSCIENCE (2010)
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Javier Palazuelos et al.
BRAIN (2009)
The endocannabinoid system as a target for the treatment of motor dysfunction
Javier Fernandez-Ruiz
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Jonathan Z. Long et al.
NATURE CHEMICAL BIOLOGY (2009)
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
Matthew N. Hill et al.
PSYCHONEUROENDOCRINOLOGY (2009)
CB Receptor Ligands from Plants
Rudolf Bauer et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits Diet-Induced Obese Rats
Ruben Nogueiras et al.
DIABETES (2008)
Cannabinoid ester constituents from high-potency Cannabis sativa
Safwat A. Ahmed et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Serum endocannabinoid content is altered in females with depressive disorders: A preliminary report
M. N. Hill et al.
PHARMACOPSYCHIATRY (2008)
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
Cristina Benito et al.
JOURNAL OF NEUROSCIENCE (2007)
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
Y Yiangou et al.
BMC NEUROLOGY (2006)
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro:: Relevance to Parkinson's disease
I Lastres-Becker et al.
NEUROBIOLOGY OF DISEASE (2005)
Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum:: A combined immunochemical and pharmacological analysis
A Köfalvi et al.
JOURNAL OF NEUROSCIENCE (2005)
Cannabis as a risk factor for psychosis: systematic review
DM Semple et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
MN Hill et al.
BEHAVIOURAL PHARMACOLOGY (2005)
The endocannabinoid system and its therapeutic exploitation
V Di Marzo et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: A pilot study
KA Sieradzan et al.
NEUROLOGY (2001)
Share Paper
